Publications 2026

Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa K, Almaas VM (2026)
Evaluating ECG Criteria for Diagnosing Left Ventricular Hypertrophy in Anabolic-Androgenic Steroid Users
JACC Adv, 5 (2), 102499 (in press)
DOI 10.1016/j.jacadv.2025.102499, PubMed 41534381

Publications 2025

Scarth M, Abdullah R, Almaas VM, Bjørnebekk AK (2025)
Associations between types of anabolic androgenic steroids and growth hormone and adverse effects: Insights from a male cohort study
Performance Enhancement & Health, 13 (3), 100337
DOI 10.1016/j.peh.2025.100337, PublikaID 545

Publications 2024

Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa KH, Almaas VM (2024)
Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids
Eur J Prev Cardiol, 31 (5), 599-608
DOI 10.1093/eurjpc/zwad362, PubMed 37992194

Almaas VM, Abdullah R, Edvardsen T, Haugaa KH, Bjørnebekk A (2024)
Comment on 'Anabolic-androgenic steroids and cardiac function'
Eur J Prev Cardiol, 31 (13), e97-e98
DOI 10.1093/eurjpc/zwae183, PubMed 38788779

Gregersen I, Scarth ME, Abdullah R, Thorsby PM, Hauger LE, Haugaa KH, Sagen EL, Michelsen AE, Ueland T, Edvardsen T, Aukrust P, Almaas VM, Bjørnebekk AK, Halvorsen B (2024)
Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of anabolic-androgenic steroids
Eur J Prev Cardiol, 31 (12), 1469-1476
DOI 10.1093/eurjpc/zwae126, PubMed 38573232

Henriksen HCB, Havnes IA, Jørstad ML, Abdullah R, Thorsby PM, Hauger LE, Edvardsen T, Haugaa KH, Almaas VM, Bjørnebekk A (2024)
Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study
Scand J Med Sci Sports, 34 (1), e14554
DOI 10.1111/sms.14554, PubMed 38268076